These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Role of phosphodiesterases in the shaping of sub-plasma-membrane cAMP oscillations and pulsatile insulin secretion. Tian G; Sågetorp J; Xu Y; Shuai H; Degerman E; Tengholm A J Cell Sci; 2012 Nov; 125(Pt 21):5084-95. PubMed ID: 22946044 [TBL] [Abstract][Full Text] [Related]
64. [Familial isolated pituitary adenoma syndrome]. Dénes J; Korbonits M; Hubina E; Kovács GL; Kovács L; Görömbey Z; Czirják S; Góth M Orv Hetil; 2011 May; 152(18):722-30. PubMed ID: 21498161 [TBL] [Abstract][Full Text] [Related]
65. [Aryl hydrocarbon receptor interacting protein gene and familial isolated pituitary adenomas]. Cai F; Zhang YD; Dai CX; Liu XH; Yang YK; Yao Y; Wang RZ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):640-4. PubMed ID: 23286415 [TBL] [Abstract][Full Text] [Related]
66. In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues. Kenk M; Greene M; Thackeray J; deKemp RA; Lortie M; Thorn S; Beanlands RS; DaSilva JN Nucl Med Biol; 2007 Jan; 34(1):71-7. PubMed ID: 17210463 [TBL] [Abstract][Full Text] [Related]
67. Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland. Hernández-Ramírez LC; Morgan RML; Barry S; D'Acquisto F; Prodromou C; Korbonits M Oncotarget; 2018 Feb; 9(10):9177-9198. PubMed ID: 29507682 [TBL] [Abstract][Full Text] [Related]
70. Neuroinflammation in Ischemic Stroke: Inhibition of cAMP-Specific Phosphodiesterases (PDEs) to the Rescue. Ponsaerts L; Alders L; Schepers M; de Oliveira RMW; Prickaerts J; Vanmierlo T; Bronckaers A Biomedicines; 2021 Jun; 9(7):. PubMed ID: 34206420 [TBL] [Abstract][Full Text] [Related]
71. Differential Expression and Function of PDE8 and PDE4 in Effector T cells: Implications for PDE8 as a Drug Target in Inflammation. Vang AG; Basole C; Dong H; Nguyen RK; Housley W; Guernsey L; Adami AJ; Thrall RS; Clark RB; Epstein PM; Brocke S Front Pharmacol; 2016; 7():259. PubMed ID: 27601994 [TBL] [Abstract][Full Text] [Related]
72. The Role of PDE8 in T Cell Recruitment and Function in Inflammation. Epstein PM; Basole C; Brocke S Front Cell Dev Biol; 2021; 9():636778. PubMed ID: 33937235 [TBL] [Abstract][Full Text] [Related]
74. Correction: RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas. Garcia-Rendueles AR; Chenlo M; Oroz-Gonjar F; Solomou A; Mistry A; Barry S; Gaston-Massuet C; Garcia-Lavandeira M; Perez-Romero S; Suarez-Fariña M; Pradilla-Dieste A; Dieguez C; Mehlen P; Korbonits M; Alvarez CV Oncogene; 2023 Dec; 42(49):3655-3656. PubMed ID: 37932482 [No Abstract] [Full Text] [Related]
75. Genetic and Epigenetic Causes of Pituitary Adenomas. Chang M; Yang C; Bao X; Wang R Front Endocrinol (Lausanne); 2020; 11():596554. PubMed ID: 33574795 [TBL] [Abstract][Full Text] [Related]
76. Trofimiuk-Müldner M; Domagała B; Sokołowski G; Skalniak A; Hubalewska-Dydejczyk A Front Endocrinol (Lausanne); 2023; 14():1098367. PubMed ID: 36843582 [TBL] [Abstract][Full Text] [Related]
77. Computational study on new natural compound agonists of dopamine receptor. Li H; Yang W; Xi J; Wang Z; Lu H; Du Z; Li W; Wu B; Jiang S; Peng Y; Liu J; Liu L; Zhang X; Feng J Aging (Albany NY); 2021 Jun; 13(12):16620-16636. PubMed ID: 34170848 [TBL] [Abstract][Full Text] [Related]
78. Oncogene-induced DNA damage: cyclic AMP steps into the ring. Fagin JA; Petrini JH J Clin Invest; 2020 Nov; 130(11):5668-5670. PubMed ID: 32986019 [TBL] [Abstract][Full Text] [Related]
79. Phosphodiesterases and cAMP Pathway in Pituitary Diseases. Bizzi MF; Bolger GB; Korbonits M; Ribeiro-Oliveira A Front Endocrinol (Lausanne); 2019; 10():141. PubMed ID: 30941100 [TBL] [Abstract][Full Text] [Related]
80. Reduced protein expression of the phosphodiesterases PDE4A4 and PDE4A8 in AIP mutation positive somatotroph adenomas. Bizzi MF; Pinheiro SVB; Bolger GB; Schweizer JROL; Giannetti AV; Dang MN; Ribeiro-Oliveira A; Korbonits M Mol Cell Endocrinol; 2018 Nov; 476():103-109. PubMed ID: 29729370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]